These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1295414)

  • 1. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment.
    Lye WC; Lee EJ
    Ann Acad Med Singap; 1992 Nov; 21(6):760-4. PubMed ID: 1295414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
    Ittel TH; Schäfer C; Schmitt H; Gladziwa U; Sieberth HG
    Klin Wochenschr; 1991 Jan; 69(2):59-67. PubMed ID: 2027271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteodystrophy in Indonesian haemodialysis patients.
    Santoso D; Yogiantoro M; Tomino Y
    Nephrology (Carlton); 2003 Oct; 8(5):261-5. PubMed ID: 15012715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
    Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
    Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical and histological spectrum of renal osteodystrophy in Argentina].
    Douthat WG; Garay G; de Arteaga J; Fernández Martín JL; Cannata Andía JB; Massari PU
    Nefrologia; 2003; 23 Suppl 2():47-51. PubMed ID: 12778854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
    Bervoets AR; Spasovski GB; Behets GJ; Dams G; Polenakovic MH; Zafirovska K; Van Hoof VO; De Broe ME; D'Haese PC
    Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
    Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
    Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.
    Gerakis A; Hutchison AJ; Apostolou T; Freemont AJ; Billis A
    Nephrol Dial Transplant; 1996 Dec; 11(12):2430-8. PubMed ID: 9017618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
    Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
    Ahmed KY; Varghese Z; Meinhard EA; Baillod RA; Skinner RK; Wills MR; Moorhead JF
    Adv Exp Med Biol; 1977; 81():581-90. PubMed ID: 899942
    [No Abstract]   [Full Text] [Related]  

  • 14. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
    Gal-Moscovici A; Popovtzer MM
    Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G; Schaefer K; Schulz A; Delling G
    Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
    Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
    Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.
    Changsirikulchai S; Domrongkitchaiporn S; Sirikulchayanonta V; Ongphiphadhanakul B; Kunkitti N; Stitchantrakul W; Radienahamed P
    J Med Assoc Thai; 2000 Oct; 83(10):1223-32. PubMed ID: 11143489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
    Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
    Navarro JF; Mora C; Macia M; Garcia J
    Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.